ALLIANCEBERNSTEIN L.P. - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 208 filers reported holding AMICUS THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$3,414,752
-10.1%
344,229
+6.8%
0.00%0.0%
Q1 2024$3,797,389
-21.4%
322,359
-5.3%
0.00%
-50.0%
Q4 2023$4,829,552
+17.7%
340,349
+0.9%
0.00%0.0%
Q3 2023$4,102,164
-3.2%
337,349
-0.0%
0.00%0.0%
Q2 2023$4,237,480
+20.9%
337,379
+6.8%
0.00%0.0%
Q1 2023$3,503,985
-9.2%
315,959
+0.0%
0.00%0.0%
Q4 2022$3,857,493
+17.4%
315,929
+0.4%
0.00%0.0%
Q3 2022$3,286,000
-58.4%
314,729
-57.3%
0.00%
-50.0%
Q2 2022$7,907,000
+22.5%
736,265
+8.0%
0.00%
+100.0%
Q1 2022$6,457,000
-22.5%
681,845
-5.5%
0.00%
-33.3%
Q4 2021$8,330,000
+18.1%
721,225
-2.4%
0.00%0.0%
Q3 2021$7,054,000
+92.9%
738,648
+94.7%
0.00%
+200.0%
Q2 2021$3,657,000
-3.4%
379,400
-1.0%
0.00%
-50.0%
Q1 2021$3,785,000
-68.7%
383,100
-26.9%
0.00%
-66.7%
Q4 2020$12,108,000
+63.5%
524,3660.0%0.01%
+50.0%
Q3 2020$7,404,000
-16.0%
524,366
-10.3%
0.00%
-20.0%
Q2 2020$8,819,000
+166.6%
584,836
+63.3%
0.01%
+150.0%
Q1 2020$3,308,000
-36.1%
358,036
-32.6%
0.00%
-33.3%
Q4 2019$5,177,000
+101.7%
531,503
+66.0%
0.00%
+50.0%
Q3 2019$2,567,000
-35.7%
320,1360.0%0.00%0.0%
Q2 2019$3,995,000
+9.3%
320,136
+19.1%
0.00%0.0%
Q1 2019$3,656,000
-25.9%
268,836
-47.8%
0.00%
-50.0%
Q4 2018$4,932,000
+53.2%
514,836
+93.3%
0.00%
+100.0%
Q3 2018$3,220,000
-22.6%
266,3360.0%0.00%
-33.3%
Q2 2018$4,160,000
+25.6%
266,336
+21.0%
0.00%
+50.0%
Q1 2018$3,311,000
-10.4%
220,136
-14.3%
0.00%
-33.3%
Q4 2017$3,696,000
-27.4%
256,846
-24.0%
0.00%
-25.0%
Q3 2017$5,094,000
+145.7%
337,826
+64.1%
0.00%
+100.0%
Q2 2017$2,073,000
+64.3%
205,836
+16.3%
0.00%
+100.0%
Q1 2017$1,262,000
-85.9%
177,036
-90.2%
0.00%
-85.7%
Q4 2016$8,967,000
-34.3%
1,804,222
-2.2%
0.01%
-41.7%
Q3 2016$13,650,000
+18.9%
1,844,529
-12.3%
0.01%
+20.0%
Q2 2016$11,478,000
-23.6%
2,102,242
+18.2%
0.01%
-23.1%
Q1 2016$15,025,000
-29.4%
1,778,151
-18.9%
0.01%
-27.8%
Q4 2015$21,272,000
-23.2%
2,192,974
+10.8%
0.02%
-25.0%
Q3 2015$27,701,000
+1140.5%
1,980,077
+1154.8%
0.02%
+1100.0%
Q2 2015$2,233,000
+5482.5%
157,800
+4164.9%
0.00%
Q1 2015$40,000
+29.0%
3,7000.0%0.00%
Q4 2014$31,000
-81.0%
3,700
-95.3%
0.00%
Q1 2014$163,000
-15.5%
78,565
-4.5%
0.00%
Q4 2013$193,000
-13.1%
82,265
-14.0%
0.00%
Q3 2013$222,000
-1.8%
95,665
-1.6%
0.00%
Q2 2013$226,00097,1910.00%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Perceptive Advisors 12,339,444$73,420,0007.88%
Redmile Group, LLC 5,706,906$33,956,0003.92%
NEA Management Company, LLC 5,653,029$33,636,0001.71%
SOUND ENERGY PARTNERS, INC. 261,416$1,555,0001.20%
Palo Alto Investors LP 1,956,376$11,640,0000.87%
EAM Investors, LLC 612,199$3,643,0000.74%
Atika Capital Management LLC 130,000$774,0000.60%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 1,231,116$7,325,0000.48%
P.R. Herzig & Co. Inc. 53,000$315,0000.47%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 248,383$1,478,0000.38%
View complete list of AMICUS THERAPEUTICS INC shareholders